Goudie Joy S. 4

What Happened

• Joy S. Goudie, a director of Daxor Corporation (DXR), was granted 2,500 stock options (derivative award) on June 23, 2026. The Form 4 reports an acquisition price of $0.00 because this is an option grant rather than a share purchase. The grant is recorded as Transaction Code "A" (award/grant).

Key Details

• Transaction date: June 23, 2026; Form 4 filed June 25, 2026 (timely within the 2-business-day window).
• Reported amount: 2,500 stock options; reported value on the Form 4: $0 (derivative award).
• Vesting schedule (per filing footnote): 833 options vest on Jun 23, 2026; 883 options vest on Jun 23, 2027; 834 options vest on Jun 23, 2028.
• Contingency: Grant is contingent on SEC approval to amend Daxor’s 2020 Incentive Compensation Plan.
• Shares owned after the transaction: Not specified in this Form 4 filing.
• Filing timeliness: Filed two days after the transaction date (appears timely).

Context

• This filing documents a director compensation grant (options), not an open-market buy or sale of shares. Because the grant depends on a plan amendment and vests in installments, its ultimate economic impact depends on future SEC approval, vesting, and any later exercise or sale — each of which would generate new filings.